Delivery Order SPE2DR25D1205-SPE2DR26F1HE3
- Not listed
- The Defense Logistics Agency issued a $12,331.61 delivery order to Amerisourcebergen Drug Corp on May 1, 2026, for VEMLIDY 25 MG tablets (30-count unit of use packaging). The order closes May 4, 2026. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc. Place of performance is Conshohocken, PA. The order is priced firm fixed-price with no set-aside used. This delivery order is issued against the awardee's parent indefinite delivery contract...
- The Defense Logistics Agency issued a $28,295.42 delivery order to Amerisourcebergen Drug Corp on April 16, 2026, for VEMLIDY 25 mg tablets (30-count units). The order is firm fixed price with an ultimate completion date of April 17, 2026. Place of performance is Conshohocken, PA. No set-aside was used. Amerisourcebergen is a pharmaceutical distributor and subsidiary of Cencora, Inc., holding a single-award indefinite delivery contract with the Defense Logistics Agency valued at $4.999 million...
- The Defense Logistics Agency issued a $3,130.62 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for VEMLIDY 25 mg tablets. Place of performance is Conshohocken, PA. Ultimate completion date is May 7, 2026. The order is firm fixed-price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying the Defense Logistics Agency under standing indefinite delivery contracts for military healthcare supply.
- The Defense Logistics Agency issued a $3,126.96 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for VEMLIDY 25 MG tablets (30-count unit dose), firm fixed-price, with completion by May 7, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen Drug Corp operates as a pharmaceutical distributor subsidiary of Cencora, Inc., supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to Defense Health...
- The Defense Logistics Agency issued a $15,140.28 delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for VEMLIDY 25 mg tablets (30-count unit of use packaging). Ultimate completion is April 24, 2026. Place of performance is Conshohocken, PA. The order is priced as firm fixed price with no set-aside applied. This represents a transactional pharmaceutical delivery under the DLA Troop Support Medical indefinite delivery contract vehicle, reflecting the company's role as a standing...
- The Defense Logistics Agency issued a $23,969.14 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for VEMLIDY 25 mg tablets (30-count units). The order carries a firm fixed price and closes on March 12, 2026. Place of performance is Conshohocken, PA. This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract with Amerisourcebergen Drug Corp (parent entity Cencora, Inc.), a pharmaceutical distributor supplying military healthcare systems...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $6,690.78 to Amerisourcebergen Drug Corporation for VEMLIDY 25 MG tablets. Amerisourcebergen will deliver 30 tablets to a location in Conshohocken, Pennsylvania by August 22, 2023 in support of DLA's pharmaceutical distribution requirements. As the prime contractor, Amerisourcebergen will utilize its corporate office and distribution division capabilities. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $4,501.28 to Amerisourcebergen Drug Corporation for the supply of 4561770570 VEMLIDY 25 MG TABLETS. The contract has a period of performance from August 10, 2023 through August 11, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. As a major distributor of pharmaceuticals and medical supplies to the U.S. Department of Defense, this delivery order...
- The Defense Logistics Agency issued a $33,040.30 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for VEMLIDY 25 mg tablets (30-count units). The order was placed under the Defense Logistics Agency Troop Support Medical IDC, a single-award indefinite delivery contract supporting pharmaceutical and medical supply distribution to military healthcare systems globally. Place of performance is Conshohocken, PA. The ultimate completion date is April 28, 2026. Pricing is firm fixed...
- The Defense Logistics Agency issued a $7,675.36 delivery order to AmerisourceBergen Drug Corp on March 23, 2026, for VEMLIDY 25 MG tablets (30-count units), firm fixed price, with an ultimate completion date of March 24, 2026. Place of performance is Conshohocken, PA. The order was issued under the DLA Troop Support Medical indefinite delivery contract with a ceiling value of $999,999,999.00 running through December 2026, which provides pharmaceutical and medical supply distribution globally...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1HE3Delivery Order
The Defense Logistics Agency issued a $11,634.03 delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for VEMLIDY 25 MG tablets (30-count unit of use packaging), with ultimate completion May 7, 2026. This is a firm fixed-price pharmaceutical delivery order. Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution, operating as a pharmaceutical distributor and medical supplier delivering brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices to federal healthcare systems. The company holds a single-award indefinite delivery contract with DLA Troop Support Medical valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 5/5/26 |